Keywords: فاکتور H; FB; factor B; TCC; terminal complement complex; FH; factor H; Clu; clusterin; C1Inh; C1 inhibitor; CRP; C-reactive protein; ELISA; enzyme linked immunosorbent assay; AED; anti-epileptic drugs; CNS; central nervous system; WNRTB; Wales Neuroscience Researc
مقالات ISI فاکتور H (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: فاکتور H; C3aR; C3a receptor; C5aR1/2; C5a receptor 1/2; CLP; cecal ligation and puncture; CXCR4; C-X-C chemokine receptor type 4; DAMPs/PAMPs; damage-/pathogen-associated molecular patterns; Efb; extracellular fibrinogen-binding protein; ERK; extracellular signal-
Keywords: فاکتور H; AMOP; adhesion-associated domain present in MUC4 and other proteins; C4BP; C4b-binding protein; CCP; complement control protein; CR1; complement receptor 1; CR3; complement receptor 3; CS; chondroitin sulfate; CSMD; CUB and Sushi multiple domains; DAF; de
Keywords: فاکتور H; Autoimmunity; Age-related macular degeneration; Autoantibodies; Complement factors; Factor H; Cytokines; IL-17; Chemokines; Retina; Aging;
Keywords: فاکتور H; Leptospira; Enolase; Plasminogen; C4b binding protein; Factor H;
Keywords: فاکتور H; SCR; short consensus repeats; GBM; glomerular basement membrane; HSPG; heparan sulfate proteoglycans; Glomerular basement membrane; Heparan sulfate; Complement; Factor H; Alternative pathway;
Keywords: فاکتور H; Complement; Factor H; Factor H-related proteins; CFHRs; C3; Disease susceptibility;
Keywords: فاکتور H; anti-B PS IgM Ab; anti-serogroup B capsular polysaccharide IgM antibodies; BCA; bactericidal activity test; CFU; colony forming unit; ELISA; enzyme-linked immunosorbent assay; fH; factor H; fHbp; factor H-binding protein; GMT; geometric mean titre; IMD; i
Keywords: فاکتور H; Ab; antibody/antibodies; MBL; mannose binding lectin/s; Ag; antigen/s; FH; Factor H; FI; Factor I; MAC; membrane attack complex; mAb; monoclonal antibody/ies; TF; tissue factor; HF; hemorrhagic fever; APLS; anti-phospholipid syndrome; aPL; anti-phospholip
Keywords: فاکتور H; Complement; Autoantibodies; C1q; Factor H;
Keywords: فاکتور H; Complement; glomerulonephritis; factor H; thrombotic microangiopathy; membranous nephropathy;
Keywords: فاکتور H; Complement; eculizumab; factor H; factor I; hemolytic uremic syndrome; membrane cofactor protein; thrombomodulin; transplantation;
Keywords: فاکتور H; Neisseria meningitidis; Vaccine; Complement; Factor H; Factor H-binding protein; Transgenic mouse; OMV; Outer membrane vesicle; Bexsero
Keywords: فاکتور H; MSC; Complement; Neutrophil; Therapy; Factor H
C3 Glomerulopathy: Ten Years' Experience at Mayo Clinic
Keywords: فاکتور H; AP; alternative pathway; C3G; C3 glomerulopathy; C3GN; C3 glomerulonephritis; C3Nef; C3 nephritic factor; C5Nef; C5 nephritic factor; CFB; complement factor B; CFH; complement factor H; CR; complete remission; DDD; dense deposit disease; eGFR; estimated g
Alternative pathway activation due to low level of complement factor H in primary antiphospholipid syndrome
Keywords: فاکتور H; aHUS; atypical hemolytic uremic syndrome; aPL; antiphospholipid antibodies; APS; antiphospholipid syndrome; CRF; complement regulatory factors; CTD; connective tissue diseases; ELISA; enzyme-linked immunosorbent assays; FH; factor H; HRP; hydrogen peroxid
The functional activities of complement factor H are impaired in patients with ANCA-positive vasculitis
Keywords: فاکتور H; ANCA; Vasculitis; Complement; Factor H;
ReviewComplement's hidden arsenal: New insights and novel functions inside the cell
Keywords: فاکتور H; CP; classical pathway; LP; lectin pathway; AP; alternative pathway; MAC; membrane attack complex; FB; factor B; FH; factor H; DAMP; damage-associated molecular pattern; mTOR; mammalian target of rapamycin; CCP; complement control protein; Complement; T ce
Complement activation, inflammation and relative ADAMTS13 deficiency in secondary thrombotic microangiopathies
Keywords: فاکتور H; Secondary thrombotic microangiopathy; Complement activation; Relative ADAMTS13 deficiency; In-hospital mortality; Factor H;
Elevated factor H-related protein 1 and factor H pathogenic variants decrease complement regulation in IgA nephropathy
Keywords: فاکتور H; CFH mutation; complement alternative pathway; factor H; factor H-related proteins; IgAN;
Potential influences of complement factor H in autoimmune inflammatory and thrombotic disorders
Keywords: فاکتور H; aHUS; atypical haemolytic uremic syndrome; AMD; age-related macular degeneration; aPL; anti-phospholipid antibodies; C3-NeF; C3- nephritic factor; CCP; complement control protein; CEP; Carboxyethylpyrrole; CL; Cardiolipin; CNV; copy number variation; CR;
Contribution of the outer membrane protein OmpW in Escherichia coli to complement resistance from binding to factor H
Keywords: فاکتور H; Outer membrane protein OmpW; β-barrel; Complement; Alternative pathway; Factor H
Alternative pathway regulation by factor H modulates Streptococcus pneumoniae induced proinflammatory cytokine responses by decreasing C5a receptor crosstalk
Keywords: فاکتور H; Streptococcus pneumoniae; C5aR crosstalk; Proinflammatory cytokines; Factor H; Complement; Alternative pathway;
Complement Receptor 2 is increased in cerebrospinal fluid of multiple sclerosis patients and regulates C3 function
Keywords: فاکتور H; CR2; Complement Receptor 2; CSF; cerebrospinal fluid; EDSS; Extended Disability Status Scale; fI; factor I; fH; factor H; MSSS; Multiple Sclerosis Severity Score; NFL; neurofilament-light; OND; other neurological disease; RCA; regulator of complement acti
Acquisition of negative complement regulators by the saprophyte Leptospira biflexa expressing LigA or LigB confers enhanced survival in human serum
Keywords: فاکتور H; Leptospira; Complement; Immune evasion; Lig proteins; Factor H; C4BP
Full length articleSulfated alginate microspheres associate with factor H and dampen the inflammatory cytokine response
Keywords: فاکتور H; Alginate; Complement; Cytokines; Factor H; Sulfated alginate;
Thrombomodulin enhances complement regulation through strong affinity interactions with factor H and C3b-Factor H complex
Keywords: فاکتور H; AP; alternative pathway; CH50; the amount of serum (μl) giving 50% hemolysis of sheep erythrocytes; CFD; complement fixation diluents buffer; CP; classical pathway; DIC; disseminated intravascular coagulation; EGF; endothelial growth factor domain; FB; F
Aged complement factor H knockout mice kept in a clean barriered environment have reduced retinal pathology
Keywords: فاکتور H; Age-related macular degeneration; Factor H; Pathogens; Inflammation;
Characterization of the gene encoding component C3 of the complement system from the spider Loxosceles laeta venom glands: Phylogenetic implications
Keywords: فاکتور H; C3; complement C3; FB; factor B; A2M; alpha-2 macroglobulin; TEP; thioester-containing proteins; TED; thioester domain; ANA; anaphylatoxin; MG; macroglobulin; C345c; C-terminal of C3, C4 and C5; FH; factor H; CR1; complement receptor 1; CR2; complement re
Utilizing complement evasion strategies to design complement-based antibacterial immunotherapeutics: Lessons from the pathogenic Neisseriae
Keywords: فاکتور H; NulO; nonulosonate; LOS; lipooligosaccharide; LNnT; lacto-N-neotetraose; Lst; LOS sialyltransferase; FH; factor H; FB; factor B; FD; factor D; MASP-2; Mannan binding lectin associated serine protease 2; FHL-1; Factor H-like protein 1; FHR-1; Factor H-rela
Factor H inhibits complement activation induced by liposomal and micellar drugs and the therapeutic antibody rituximab in vitro
Keywords: فاکتور H; AP; alternative pathway of complement; CARPA; complement activation-related pseudoallergy; CCP; complement control protein domain; CFHR1; factor H-related protein 1; CrEL; Cremophor EL; FH; factor H; FH1-4; CCPs 1-4 of FH; FH15-20; CCPs 15-20 of FH; mAb;
CD55, CD59, factor H and factor H-like 1 gene expression analysis in tumors of the ovary and corpus uteri origin
Keywords: فاکتور H; CD55; CD59; Factor H; Factor H-like 1; Gynecological cancer;
Effect of complement Factor H on anti-FHbp serum bactericidal antibody responses of infant rhesus macaques boosted with a licensed meningococcal serogroup B vaccine
Keywords: فاکتور H; Neisseria meningitidis; Vaccine; Complement; Factor H; Factor H binding protein; Non-human primate; 4CMenB; Bexsero®;
Secreted aspartic protease 2 of Candida albicans inactivates factor H and the macrophage factor H-receptors CR3 (CD11b/CD18) and CR4 (CD11c/CD18)
Keywords: فاکتور H; CCP; complement control protein domain; CR3; complement receptor type 3 (CD11b/CD18); CR4; complement receptor type 4 (CD11c/CD18); FH; factor H; MDM; monocyte-derived macrophages; Sap2; secreted aspartic protease 2; Candida albicans; Complement; CR3; Fac
An extended mini-complement factor H molecule ameliorates experimental C3 glomerulopathy
Keywords: فاکتور H; C3 glomerulopathy; factor H; mini-FH; therapeutic;
Of mice and men: The factor H protein family and complement regulation
Keywords: فاکتور H; Complement; Regulation; Factor H; Mouse; Human
The molecular and structural bases for the association of complement C3 mutations with atypical hemolytic uremic syndrome
Keywords: فاکتور H; AP; alternative pathway; aHUS; atypical hemolytic uremic syndrome; CP; classical pathway; CR1; complement receptor 1; DAF; decay accelerating factor; DDD; dense deposit disease; EM; electron microscopy; FB; factor B; FD; factor D; FH; factor H; FI; factor
Factor H-related proteins determine complement-activating surfaces
Keywords: فاکتور H; complement; factor H; factor H-related proteins; CFHRs; disease susceptibility
Ultralarge Von Willebrand Factor-Induced Platelet Clumping and Activation of the Alternative Complement Pathway in Thrombotic Thrombocytopenic Purpura and the Hemolytic-Uremic Syndromes
Keywords: فاکتور H; VWF; Alternative complement pathway; Factor H; Thrombotic microangiopathies;
Innate immune humoral factors, C1q and factor H, with differential pattern recognition properties, alter macrophage response to carbon nanotubes
Keywords: فاکتور H; Carbon nanotubes; Nanotherapeutics; Immune system; Innate immunity; Complement; C1q; Factor H;
A potential anti-coagulant role of complement factor H
Keywords: فاکتور H; APS; anti-phospholipid syndrome; β2-GP1; beta 2-glycoprotein 1; FH; factor H; SLE; systemic lupus erythematosus; CCP; complement control protein; CL; cardiolipin; PS; phosphatidylserine; aPL; anti-phospholipid autoantibodies; Factor H; complement; coagul
Interaction of Shiga toxin 2 with complement regulators of the factor H protein family
Keywords: فاکتور H; EHEC; enterohemorrhagic Escherichia coli; FH; factor H; FHL-1; factor H-like protein 1; FHR-1; factor H-related protein 1; FI; factor I; HUS; hemolytic uremic syndrome; aHUS; atypical HUS; MCP; membrane cofactor protein; SCRs; short consensus repeats; Stx
Autoantibodies to complement components in C3 glomerulopathy and atypical hemolytic uremic syndrome
Keywords: فاکتور H; Autoantibodies; Kidney disease; Atypical hemolytic uremic syndrome; C3 glomerulopathy; Complement regulation; C3 convertase; Factor B; Factor H; C3 nephritic factor
Glomerulopatía C3: una nueva entidad basada en el complemento
Keywords: فاکتور H; Glomerulopatía C3; Enfermedad por depósitos densos; Vía alternativa del complemento; Factor H; Factor I; Factor nefrítico C3; EculizumabC3 glomerulopathy; Dense-deposit disease; Alternative complement pathway; Factor H; Factor I; C3 nephritic factor; Ecul
C3 glomerulopathy: A new complement-based entity
Keywords: فاکتور H; C3 glomerulopathy; Dense-deposit disease; Alternative complement pathway; Factor H; Factor I; C3 nephritic factor; EculizumabGlomerulopatía C3; Enfermedad por depósitos densos; Vía alternativa del complemento; Factor H; Factor I; Factor nefrítico C3; Ecul
fH-dependent complement evasion by disease-causing meningococcal strains with absent fHbp genes or frameshift mutations
Keywords: فاکتور H; fH; factor H; fHbp; factor H-binding protein; NspA; Neisseria surface protein A; Neisseria meningitidis; Vaccine; Complement; Factor H; fHbp; NspA; Transgenic rat;
Targeted inhibition of complement using complement receptor 2-conjugated inhibitors attenuates EAE
Keywords: فاکتور H; CR2; complement receptor 2; Crry; complement receptor related protein y; fH; factor H; Experimental autoimmune encephalomyelitis; Neuroimmunology complement; Immunology; Autoimmune disease;
Secondary Focal and Segmental Glomerulosclerosis Associated With Single-Nucleotide Polymorphisms in the Genes Encoding Complement Factor H and C3
Keywords: فاکتور H; Focal and segmental glomerulosclerosis (FSGS); chronic thrombotic microangiopathy; alternative pathway of complement; factor H; C3;
Factor H autoantibodies in membranoproliferative glomerulonephritis
Keywords: فاکتور H; Factor H; Complement; MPGN; Autoantibodies
Factor H as a regulator of the classical pathway activation
Keywords: فاکتور H; CL; cardiolipin; MBL; mannan-binding lectin; PI; phosphatidylinositol; PA; dipalmitoylphosphatidic acid; PG; phosphatidylglycerol; PS; phosphatidylserine; PE; dimyristoylphosphatidylethanolamine; PC; phosphatidylcholine; MASP; MBL-associated serine protea